Instrument NameAbbott LaboratoriesInstrument Symbol(ABT-N)

Instrument ExchangeNYSE

ABT earnings call for the period ending March 31, 2024.

Abbott Laboratories on Wednesday reported first-quarter profit of $1.23 billion

Abbott Laboratories (ABT) beat Wall Street estimates for its first quarter financial results due to ...

June S&P 500 E-Mini futures (ESM24) are trending up +0.39% this morning as market participants moved past hawkish comments from Federal Reserve Chair Jerome Powell and looked ahead to the next round of corporate earnings.

June S&P 500 E-Mini futures (ESM24) are up +0.44%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.52% this morning as market participants wagered that tensions in the Middle East won’t escalate following Iran’s unprecedented attack on Israel over the weekend, with the focus shifting to Wall Street’s earnings season, key economic data releases, and a parade of Fed speakers.

Monday U.S. Economic Lookahead Retail Sales (March) Business inventories (Feb.) ...

These companies provide stability, reliability, and passive income.

Income-seeking investors can look forward to steady payout raises from these pharma stocks.

Each of these high-quality stocks looks like a buy.

These three stocks have earned the title of Dividend Kings by consistently increasing dividends for at least 50 years.

There aren't many guarantees in the equity market, but the dividend payouts of Johnson & Johnson and Abbott Laboratories may be as close as it gets to a sure thing.

/CNW/ -- Abbott (NYSE: ABT) today announced that the company's Eterna™ SCS system – the smallest implantable, rechargeable spinal cord stimulator (SCS) for the...

The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.65%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.15%. Stocks on Friday posted moderate losses, with the Nasdaq 100 falling to a 3-week...

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.82%. Stocks this morning are moderately lower, with the Nasdaq 100 falling to a...

These are some of the best-performing stocks in what's arguably society's most important industry.

Abbott Laboratories has been growing its dividend at a blistering pace. Is its stock a buy?

There is a world of opportunities ahead for this healthcare giant.

Healthcare blue chips can provide retirees the consistency they need while growing their nest eggs further.

These stocks don't offer the highest yields, but their payouts are growing fast.

Abbott's earnings have soared over the past decade.

These stocks reward you during any market environment.

Abbott Labs has an impressive portfolio of nutrition drinks, and its latest addition could help it profit from a new market: people taking prescribed weight loss drugs.

There's room for multiple winners in the fast-growing weight-loss market.

Healthcare is an excellent place to find some tried and true wealth compounders.

It's not too late to invest in these stocks.